All Employer Tests

The High-Sensitivity C-Reactive Protein (hs-CRP) Test measures very low levels of CRP in blood to evaluate inflammation and cardiovascular risk. Elevated hs-CRP may indicate increased risk for heart disease, heart attack, or stroke even before symptoms appear. Doctors use this test along with cholesterol and other markers to assess overall heart health, guide prevention strategies, and monitor treatment. It also helps evaluate chronic inflammation and metabolic conditions.

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

The Estradiol (E2) Test measures levels of estradiol, the primary form of estrogen, to evaluate reproductive and hormonal health. It helps assess menstrual irregularities, fertility issues, menopause status, and estrogen-producing disorders. In men, it aids in diagnosing hormonal imbalances. Doctors use the estradiol test to monitor hormone therapy, ovarian function, and conditions affecting puberty, bone health, and overall endocrine balance.

The Follicle-Stimulating Hormone (FSH) Test measures FSH levels to evaluate reproductive and endocrine health in both men and women. In women, it helps assess infertility, irregular periods, menopause, or ovarian function. In men, it is used to check sperm production and testicular function. Abnormal results may indicate PCOS, pituitary disorders, or hormonal imbalance. Doctors order this test to guide fertility treatment, hormone therapy, and overall reproductive care.

The Glucose-6-Phosphate Dehydrogenase (G6PD) Test measures enzyme activity to detect G6PD deficiency, a genetic condition that can lead to hemolytic anemia when exposed to certain foods, infections, or medications. Doctors order this test to assess unexplained anemia, jaundice, or family history of G6PD deficiency. Results help identify individuals at risk for red blood cell breakdown, guiding treatment, prevention, and safe medication use.

The Hemoglobin A1c (HbA1c) Test measures average blood glucose over 2–3 months by detecting sugar attached to hemoglobin in red blood cells. It is used to diagnose diabetes, identify prediabetes, and monitor long-term blood sugar control. Doctors rely on the HbA1c test to evaluate treatment effectiveness, guide adjustments, and assess risk for complications, making it essential for diabetes care and metabolic health screening.

The Hemoglobin A1c with eAG Test measures average blood sugar levels over the past 2–3 months and provides an estimated average glucose (eAG) value for easier understanding. It is widely used to screen, diagnose, and monitor diabetes and prediabetes. Doctors use this test to evaluate long-term glucose control, adjust treatment, and reduce the risk of complications such as neuropathy, kidney disease, and heart problems linked to poor blood sugar management.

The Iron Total and Total Iron Binding Capacity (TIBC) Test measures iron levels in blood along with the blood’s ability to transport iron. It helps diagnose iron deficiency anemia, iron overload (hemochromatosis), and monitor nutritional or chronic health conditions. Low iron or high TIBC may indicate anemia, while high iron or low TIBC can suggest overload. Doctors use this test to evaluate fatigue, weakness, or other symptoms linked to iron and metabolic health.

The LH Test measures luteinizing hormone levels in blood to assess fertility, reproductive health, and endocrine function. Abnormal LH may indicate infertility, menstrual irregularities, menopause, or pituitary disorders in women, and low testosterone or testicular dysfunction in men. Doctors use this test to evaluate ovulation, investigate infertility, monitor puberty disorders, or guide hormone therapy. It provides key insight into reproductive and hormonal balance.

The Lipid Panel Test checks six key blood lipids: total cholesterol, HDL cholesterol, LDL cholesterol, non-HDL cholesterol, triglycerides, and the Chol/HDL ratio. This panel assesses risk for cardiovascular disease, heart attack, and stroke by evaluating cholesterol balance and fat levels in the blood. Doctors use lipid panel results for routine screening, treatment monitoring, and guiding lifestyle or medication adjustments.

The Lipid Panel with Ratios Test measures seven key markers: total cholesterol, HDL, LDL, non-HDL cholesterol, triglycerides, Chol/HDL ratio, and LDL/HDL ratio. This advanced panel evaluates cardiovascular risk by assessing cholesterol balance and fat metabolism. Doctors use it to detect high cholesterol, atherosclerosis risk, and heart disease, and to monitor treatment. Often part of routine exams, it provides insight into long-term heart and metabolic health.

The Nicotine and Cotinine Serum/Plasma Test measures levels of nicotine and its metabolite cotinine in the blood to evaluate tobacco exposure. Cotinine provides a reliable marker due to its longer half-life, distinguishing active smoking from secondhand smoke exposure. This test supports assessment of nicotine dependence, monitoring of cessation efforts, and evaluation of environmental or occupational smoke exposure.

The Nicotine and Expanded Metabolites Test uses LC-MS/MS to detect nicotine, cotinine, and a broad panel of related metabolites in biological samples. This sensitive assay distinguishes recent and past exposure from environmental or active smoking, supports biomarker validation, and clarifies metabolite profiles. It aids clinical and research evaluation of tobacco use, nicotine metabolism variation, and exposure assessment.

The Nicotine and Expanded Metabolites Urine Test measures nicotine, cotinine, and related metabolites in urine to determine tobacco use or nicotine exposure. It is commonly used to monitor smoking status, evaluate secondhand smoke exposure, or assess the effectiveness of smoking cessation programs. The test supports health evaluations by providing data on nicotine metabolism and systemic impact.

The PSA Total Test measures prostate-specific antigen levels in blood to evaluate prostate health. Elevated PSA may indicate prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis. Doctors use this test for early detection of prostate cancer, monitoring treatment, or assessing recurrence risk. Commonly recommended for men over 50 or those at higher risk, the PSA test supports diagnosis, prevention, and long-term prostate care.